Insider Trading History of Dickman Paul

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Dickman Paul since 2017. The trader's CIK number is 1655201. At the time of the last reporting, Dickman Paul was the Chief Financial Officer of Medicine Man Technologies, Inc.. (stock ticker symbol MDCL). Also see all insider trading activities at Medicine Man Technologies, Inc..

Note that in the past Dickman Paul also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Chineseinvestors.com, Inc. (CIIX) by Dickman Paul

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 CIIX 200,000 $0 0 $0 0 $0
2016 CIIX 100,000 $0 0 $0 0 $0

Yearly summary of insider trading at Medicine Man Technologies, Inc. (MDCL) by Dickman Paul

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 MDCL 0 $0 89,747 $352,061 0 $0
2017 MDCL 0 $0 26,600 $58,718 0 $0


Insider trading activities at 2 companies by Dickman Paul:

1. Chineseinvestors.com, Inc. (CIIX)

2. Medicine Man Technologies, Inc. (MDCL)

Table 1. Insider trading of Chineseinvestors.com, Inc. (CIIX) by Dickman Paul

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-10-22 CIIX Buy 100,000 .00 0
2017-11-01 CIIX Buy 200,000 .00 0

Table 2. Insider trading of Medicine Man Technologies, Inc. (MDCL) by Dickman Paul

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-06-19 MDCL Sale 5,090 3.91 19,901
2019-06-18 MDCL Sale 74,465 3.92 291,902
2019-06-17 MDCL Sale 10,192 3.95 40,258
2017-12-29 MDCL Sale 2,808 2.22 6,233
2017-12-28 MDCL Sale 23,792 2.21 52,485

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dickman Paul (Chief Financial Officer of Medicine Man Technologies, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.